Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

15.54
+0.85005.79%
Post-market: 15.540.00000.00%18:58 EDT
Volume:81.84K
Turnover:1.27M
Market Cap:153.20M
PE:-3.33
High:16.10
Open:14.51
Low:14.51
Close:14.69
52wk High:20.21
52wk Low:3.44
Shares:9.86M
Float Shares:3.02M
Volume Ratio:0.90
T/O Rate:2.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6700
EPS(LYR):-6.6216
ROE:-383.09%
ROA:-18.79%
PB:-62.15
PE(LYR):-2.35

Loading ...

Biodesix Q3 EPS $(1.16) Beats $(1.45) Estimate, Sales $21.768M Beat $20.974M Estimate

Benzinga
·
Nov 04, 2025

BRIEF-Biodesix Q3 Revenue USD 21.8 Million Vs. IBES Estimate USD 20.8 Million

Reuters
·
Nov 04, 2025

Biodesix Reports Q3 Revenue of $21.8 Million, Up 20% Year Over Year

Reuters
·
Nov 04, 2025

Biodesix Announces Third Quarter 2025 Results and Highlights

THOMSON REUTERS
·
Nov 04, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 03, 2025

Biodesix Inc expected to post a loss of $1.44 a share - Earnings Preview

Reuters
·
Nov 01, 2025

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

GlobeNewswire
·
Oct 30, 2025

Bio-Rad Laboratories (BIO): Evaluating Valuation After Major Oncology Diagnostics Partnership Expansion with Biodesix

Simply Wall St.
·
Oct 25, 2025

Biodesix expands partnership agreement with Bio-Rad

TIPRANKS
·
Oct 22, 2025

Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

GlobeNewswire
·
Oct 22, 2025

Biodesix Inc : TD Cowen Adjusts Target Price to $40 From $2 to Reflect Reverse Stock Split

THOMSON REUTERS
·
Oct 21, 2025

Biodesix Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 20, 2025

Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting

GlobeNewswire
·
Oct 15, 2025

Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit

GlobeNewswire
·
Oct 06, 2025

Biodesix Regains Nasdaq Compliance with Bid Price

TIPRANKS
·
Oct 02, 2025

Director’s Bold Move: Massive Biodesix Stock Purchase Unveiled!

TIPRANKS
·
Sep 24, 2025

Director and 10% Owner Jack W. Schuler Reports Acquisition of Common Shares in Biodesix Inc

Reuters
·
Sep 24, 2025